4/16
03:32 pm
labp
Stockholder Alert: Ademi LLP continues Investigation of the Fairness of Landos Biopharma, Inc.'s transaction with AbbVie
Low
Report
Stockholder Alert: Ademi LLP continues Investigation of the Fairness of Landos Biopharma, Inc.'s transaction with AbbVie
4/4
04:00 pm
labp
SHAREHOLDER ALERT: Weiss Law Investigates Landos Biopharma, Inc.
Low
Report
SHAREHOLDER ALERT: Weiss Law Investigates Landos Biopharma, Inc.
4/1
08:08 am
labp
Landos Biopharma, Inc. (NASDAQ: LABP) had its "neutral" rating re-affirmed by analysts at HC Wainwright. They now have a $20.42 price target on the stock, down previously from $50.00.
Medium
Report
Landos Biopharma, Inc. (NASDAQ: LABP) had its "neutral" rating re-affirmed by analysts at HC Wainwright. They now have a $20.42 price target on the stock, down previously from $50.00.
3/27
06:04 pm
labp
LANDOS BIOPHARMA INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Landos Biopharma, Inc. - LABP
Low
Report
LANDOS BIOPHARMA INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Landos Biopharma, Inc. - LABP
3/27
11:45 am
labp
SHAREHOLDER UPDATE: Halper Sadeh LLC Investigates LABP, WRK, TGAN, KAMN
Low
Report
SHAREHOLDER UPDATE: Halper Sadeh LLC Investigates LABP, WRK, TGAN, KAMN
3/26
07:47 pm
labp
STOCKHOLDER INVESTIGATION: The M&A Class Action Firm Announces an Investigation of Landos Biopharma, Inc - LABP
Low
Report
STOCKHOLDER INVESTIGATION: The M&A Class Action Firm Announces an Investigation of Landos Biopharma, Inc - LABP
3/21
08:14 am
labp
Landos Biopharma Provides Business Update and Reports Fourth Quarter and Full Year 2023 Results [Yahoo! Finance]
Medium
Report
Landos Biopharma Provides Business Update and Reports Fourth Quarter and Full Year 2023 Results [Yahoo! Finance]
3/21
08:00 am
labp
Landos Biopharma Provides Business Update and Reports Fourth Quarter and Full Year 2023 Results
Medium
Report
Landos Biopharma Provides Business Update and Reports Fourth Quarter and Full Year 2023 Results
3/5
05:53 am
labp
Will Landos Biopharma (NASDAQ:LABP) Spend Its Cash Wisely? [Yahoo! Finance]
Low
Report
Will Landos Biopharma (NASDAQ:LABP) Spend Its Cash Wisely? [Yahoo! Finance]